Clinical trial
Effectiveness of Combined Treatment of Bupropion and Nicotine Replacement Therapy in Hospitalized Subjects With Active Smoking in a Reference Center
NCT06254001 is registered in ClinicalTrials.gov with National Institute of Respiratory Diseases, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Combined Treatment of Bupropion and Nicotine Replacement Therapy in Hospitalized Subjects With Active Smoking in a Reference Center
- Lead sponsor
- National Institute of Respiratory Diseases, Mexico
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 15, 2024
- Completion date
- June 15, 2026
- Enrollment
- 134 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nicotine addiction, nicotine replacement therapy, nicotine withdrawal, tobacco smoking, tobacco withdrawal